药易购前三季亏损去年业绩降 2021年上市申万宏源保荐

中金财经2025-10-24

中国经济网北京10月24日讯药易购(300937.SZ)昨日晚间披露2025年三季度报告。　　2025年1-9月，公司实现营业收入32.42亿元，同比增长0.21%；归属于上市公司股东的净利润为-835.65万元，上年同期为1,393.15万元；归属于上市公司股东的扣除非经常性损益的净利润为-1,015.26万元，上年同期为936.53万元；经营活动产生的现金流量净额为-1.14亿元，...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2577562385?lang=zh_CN&edition=full","thumbnail":"https://static.tigerbbs.com/ http://caiji.3g.cnfol.com/colect/202510/24/20251024943031.png?op=imageView2&mode=2&width=256&height=256&quality=70&format=png","is_english":false,"pubTime":"2025-10-24 14:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2577562385","market":"us","top_or_hot":-1,"title":"药易购前三季亏损去年业绩降 2021年上市申万宏源保荐","media":"中金财经","content":"<div>\n<p>中国经济网北京10月24日讯 药易购(300937.SZ)昨日晚间披露2025年三季度报告。\r\n\r\n　　2025年1-9月，公司实现营业收入32.42亿元，同比增长0.21%；归属于上市公司股东的净利润为-835.65万元，上年同期为1,393.15万元；归属于上市公司股东的扣除非经常性损益的净利润为-1,015.26万元，上年同期为936.53万元；经营活动产生的现金流量净额为-1.14亿元，...</p>\n\n<a href=\"http://sc.stock.cnfol.com/gushijujiao/20251024/31733744.shtml\">网页链接</a>\n\n</div>\n","source":"zhongjincaijing_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>药易购前三季亏损去年业绩降 2021年上市申万宏源保荐</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n药易购前三季亏损去年业绩降 2021年上市申万宏源保荐\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-10-24 14:34 北京时间&nbsp;&nbsp;&nbsp;<a href=http://sc.stock.cnfol.com/gushijujiao/20251024/31733744.shtml><strong>中金财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>中国经济网北京10月24日讯 药易购(300937.SZ)昨日晚间披露2025年三季度报告。\r\n\r\n　　2025年1-9月，公司实现营业收入32.42亿元，同比增长0.21%；归属于上市公司股东的净利润为-835.65万元，上年同期为1,393.15万元；归属于上市公司股东的扣除非经常性损益的净利润为-1,015.26万元，上年同期为936.53万元；经营活动产生的现金流量净额为-1.14亿元，...</p>\n\n<a href=\"http://sc.stock.cnfol.com/gushijujiao/20251024/31733744.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0276","symbol_name":"资本市场","start_time":0,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20251024/31733744.shtml","article_id":"2577562385","we_media_id":null,"thumbnails":["https://static.tigerbbs.com/ http://caiji.3g.cnfol.com/colect/202510/24/20251024943031.png?op=imageView2&mode=2&width=256&height=256&quality=70&format=png"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2577562385","pubTimestamp":1761287643,"columns":[],"sourceInfo":{"source_id":"zhongjincaijing_highlight","name":"中金在线"},"weMediaInfo":null,"summary":"中国经济网北京10月24日讯 药易购 昨日晚间披露2025年三季度报告。　　药易购于2021年1月27日在深交所创业板上市，发行数量为2391.6671万股，发行价格为12.25元/股，保荐机构为申万宏源证券承销保荐有限责任公司，保荐代表人为刘强、杨晓。　　2024年，公司实现营业收入43.81亿元，同比减少1.12%；归属于上市公司股东的净利润1635.82万元，同比减少72.52%；扣除非经常性损益后的净利润1236.97万元，同比减少77.10%；经营活动产生的现金流量净额1.28亿元，同比增长210.58%。","collect":0,"end_time":0,"defaultTopTitle":"cnfol.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"300937":"药易购","BK0276":"资本市场","BK0183":"MSCI概念","BK1147":"投资银行业与经纪业","BK0188":"融资融券","06806":"申万宏源","BK0012":"证金概念","000166":"申万宏源","BK0250":"批发","BK1564":"中资券商股","BK0028":"国家队"},"translate_title":"Yaotesco suffered losses in the first three quarters and its performance dropped last year. It will be listed in 2021. Sponsored by Shenwan Hongyuan","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300937":1.5,"000166":1.5,"06806":1.5},"content_text":"中国经济网北京10月24日讯 药易购(300937.SZ)昨日晚间披露2025年三季度报告。\r\n\r\n　　2025年1-9月，公司实现营业收入32.42亿元，同比增长0.21%；归属于上市公司股东的净利润为-835.65万元，上年同期为1,393.15万元；归属于上市公司股东的扣除非经常性损益的净利润为-1,015.26万元，上年同期为936.53万元；经营活动产生的现金流量净额为-1.14亿元，上年同期为3,831.83万元。\r\n\r\n　　    \r\n\r\n　　药易购于2021年1月27日在深交所创业板上市，发行数量为2391.6671万股，发行价格为12.25元/股，保荐机构为申万宏源证券承销保荐有限责任公司，保荐代表人为刘强、杨晓。药易购募集资金总额为2.93亿元，扣除发行费用后，募集资金净额为2.49亿元。\r\n\r\n　　药易购最终募集资金净额较原计划少1.96亿元。招股说明书显示，公司拟募集资金4.45亿元，分别用于合纵医药电商物流中心项目、药易达物流配送体系建设项目、电子商务平台优化升级项目、补充流动资金项目。\r\n\r\n　　公司上市发行费用为4350.59万元，其中保荐机构申万宏源获得承销保荐费2358.49万元。\r\n\r\n　　2024年，公司实现营业收入43.81亿元，同比减少1.12%；归属于上市公司股东的净利润1635.82万元，同比减少72.52%；扣除非经常性损益后的净利润1236.97万元，同比减少77.10%；经营活动产生的现金流量净额1.28亿元，同比增长210.58%。","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2577562385","isCrawlerRequest":true}